BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Alexopoulou A, Papatheodoridis GV. Current progress in the treatment of chronic hepatitis C. World J Gastroenterol 2012; 18(42): 6060-6069 [PMID: 23155334 DOI: 10.3748/wjg.v18.i42.6060]
URL: https://www.wjgnet.com/1007-9327/full/v18/i42/6060.htm
Number Citing Articles
1
Elif Sargin Altunok, Murat Sayan, Sila Akhan, Bilgehan Aygen, Orhan Yildiz, Suda Tekin Koruk, Resit Mistik, Nese Demirturk, Onur Ural, Şükran Kose, Aynur Aynioglu, Fatime Korkmaz, Gülden Ersoz, Nazan Tuna, Celal Ayaz, Faruk Karakecili, Derya Keten, Dilara Inan, Saadet Yazici, Safiye Koculu, Taner Yildirmak. Protease Inhibitors Drug Resistance Mutations in Turkish Patients with Chronic Hepatitis CInternational Journal of Infectious Diseases 2016; 50: 1 doi: 10.1016/j.ijid.2016.07.003
2
Kyoko Saito, Yoshitaka Shirasago, Tetsuro Suzuki, Hideki Aizaki, Kentaro Hanada, Takaji Wakita, Masahiro Nishijima, Masayoshi Fukasawa, S. Perlman. Targeting Cellular Squalene Synthase, an Enzyme Essential for Cholesterol Biosynthesis, Is a Potential Antiviral Strategy against Hepatitis C VirusJournal of Virology 2015; 89(4): 2220 doi: 10.1128/JVI.03385-14
3
Nicole Balasco, Daniela Barone, Emanuela Iaccarino, Annamaria Sandomenico, Alfonso De Simone, Menotti Ruvo, Luigi Vitagliano. Intrinsic structural versatility of the highly conserved 412–423 epitope of the Hepatitis C Virus E2 proteinInternational Journal of Biological Macromolecules 2018; 116: 620 doi: 10.1016/j.ijbiomac.2018.05.055
4
Carolina Scagnolari, Guido Antonelli. Antiviral activity of the interferon α family: biological and pharmacological aspects of the treatment of chronic hepatitis CExpert Opinion on Biological Therapy 2013; 13(5): 693 doi: 10.1517/14712598.2013.764409
5
Evangelos Cholongitas, Chrysoula Pipili, George Papatheodoridis. Interferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipientsWorld Journal of Gastroenterology 2015; 21(32): 9526-9533 doi: 10.3748/wjg.v21.i32.9526
6
Keisuke Osakabe, Naohiro Ichino, Toru Nishikawa, Hiroko Sugiyama, Miho Kato, Ai Shibata, Wakana Asada, Naoto Kawabe, Senju Hashimoto, Michihito Murao, Takuji Nakano, Hiroaki Shimazaki, Toshiki Kan, Kazunori Nakaoka, Yuka Takagawa, Masashi Ohki, Takamitsu Kurashita, Tomoki Takamura, Kentaro Yoshioka. Changes of shear-wave velocity by interferon-based therapy in chronic hepatitis CWorld Journal of Gastroenterology 2015; 21(35): 10215-10223 doi: 10.3748/wjg.v21.i35.10215
7
Longbo Hu, Wenxia Yao, Fang Wang, Xia Rong, Tao Peng, Hong Wanjin. GP73 Is Upregulated by Hepatitis C Virus (HCV) Infection and Enhances HCV SecretionPLoS ONE 2014; 9(3): e90553 doi: 10.1371/journal.pone.0090553
8
Francisco Jorquera, Francisco Ledesma, Adriana Ahumada, María Luisa Manzano, Agustín Castiella, Sara Lorente, Mireia Miquel, Zoe Mariño, José Castellote, Eva Sanz, Juan Uriz. Perfil clínico de los pacientes españoles con hepatitis C naïve con cirrosis compensada tratados en el estudio CRESTGastroenterología y Hepatología 2024;  doi: 10.1016/j.gastrohep.2024.02.003
9
Amaravadhi Harikishore, Enlin Li, Jia Jun Lee, Nam-Joon Cho, Ho Sup Yoon. Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymeraseMolecular Diversity 2015; 19(3): 529 doi: 10.1007/s11030-015-9591-5
10
Chrysoula Pipili, Evangelos Cholongitas. Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand?World Journal of Hepatology 2015; 7(12): 1606-1616 doi: 10.4254/wjh.v7.i12.1606
11
Ammar Y. Abdulrahman, Hussin A. Rothan, Nurshamimi Nor Rashid, See Khai Lim, Wajihah Sakhor, Kah Ching Tee, Teow Chong Teoh, Noorsaadah A. Rahman, Rohana Yusof. Identification of Peptide Leads to Inhibit Hepatitis C Virus: Inhibitory Effect of Plectasin Peptide Against Hepatitis C Serine ProteaseInternational Journal of Peptide Research and Therapeutics 2017; 23(2): 163 doi: 10.1007/s10989-016-9544-6
12
Ulrike Grienke, Teresa Kaserer, Florian Pfluger, Christina E. Mair, Thierry Langer, Daniela Schuster, Judith M. Rollinger. Accessing biological actions of Ganoderma secondary metabolites by in silico profilingPhytochemistry 2015; 114: 114 doi: 10.1016/j.phytochem.2014.10.010
13
Deena S. Lasheen, Mohamed A.H. Ismail, Dalal A. Abou El Ella, Nasser S.M. Ismail, Sameh Eid, Susan Vleck, Jeffrey S. Glenn, Andrew G. Watts, Khaled A.M. Abouzid. Analogs design, synthesis and biological evaluation of peptidomimetics with potential anti-HCV activityBioorganic & Medicinal Chemistry 2013; 21(10): 2742 doi: 10.1016/j.bmc.2013.03.017
14
Bassem Refaat, Ahmed Mohamed Ashshi, Adel Galal El-Shemi, Esam Azhar. Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-αBased TherapyMediators of Inflammation 2015; 2015: 1 doi: 10.1155/2015/287640
15
Clara Weil, Chizoba Nwankwo, Mira Friedman, Gabriel Kenet, Gabriel Chodick, Varda Shalev. Epidemiology of hepatitis C virus infection in a large Israeli health maintenance organizationJournal of Medical Virology 2016; 88(6): 1044 doi: 10.1002/jmv.24426
16
George V. Papatheodoridis, Emmanuel Tsochatzis, Svenja Hardtke, Heiner Wedemeyer. Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic reviewLiver International 2014; 34(10): 1452 doi: 10.1111/liv.12565
17
Makoto Ocho, Akira Togayachi, Etsuko Iio, Hiroyuki Kaji, Atsushi Kuno, Maki Sogabe, Masaaki Korenaga, Masanori Gotoh, Yasuhito Tanaka, Yuzuru Ikehara, Masashi Mizokami, Hisashi Narimatsu. Application of a Glycoproteomics-Based Biomarker Development Method: Alteration in Glycan Structure on Colony Stimulating Factor 1 Receptor as a Possible Glycobiomarker Candidate for Evaluation of Liver CirrhosisJournal of Proteome Research 2014; 13(3): 1428 doi: 10.1021/pr400986t
18
A. Hatzakis, P. Van Damme, K. Alcorn, C. Gore, M. Benazzouz, S. Berkane, M. Buti, M. Carballo, H. Cortes Martins, S. Deuffic‐Burban, A. Dominguez, M. Donoghoe, A‐N. Elzouki, N. Ben‐Alaya Bouafif, G. Esmat, R. Esteban, M. Fabri, K. Fenton, D. Goldberg, I. Goulis, T. Hadjichristodoulou, T. Hatzigeorgiou, O. Hamouda, S. Hasurdjiev, S. Hughes, A. Kautz, M. Malik, S. Manolakopoulos, M. Matičič, G. Papatheodoridis, R. Peck, A. Peterle, G. Potamitis, D. Prati, F. Roudot‐Thoraval, T. Reic, A. Sharara, M. Shennak, G. Shiha, D. Shouval, M. Sočan, H. Thomas, M. Thursz, M. Tosti, C. Trépo, A. Vince, E. Vounou, L. Wiessing, M. Manns. The State of Hepatitis B and C in the Mediterranean and Balkan Countries: Report from a Summit ConferenceJournal of Viral Hepatitis 2013; 20(s2): 1 doi: 10.1111/jvh.12120
19
Marcos Alexandre Nobre Lemos, Sandra Fernanda Suarez Patiño, Thaissa Consoni Bernardino, Ana Sofia Coroadinha, Hugo Soares, Renato Mancini Astray, Carlos Augusto Pereira, Soraia Attie Calil Jorge. Intracellular Delivery of HCV NS3p gene using vectored particlesJournal of Biotechnology 2018; 274: 33 doi: 10.1016/j.jbiotec.2018.03.010
20
Ս․Ռ․ Սարգսյան. ՔՐՈՆԻԿ ՎԻՐՈՒՍԱՅԻՆ C ՀԵՊԱՏԻՏ. ՀԱԿԱՎԻՐՈՒՍԱՅԻՆ ԲՈՒԺՄԱՆ ՓՈՒԼԵՐԸ (ՎԵՐԼՈՒԾՈՒԹՅՈՒՆ)MEDICINE, SCIENCE AND EDUCATION 2022; (33): 22 doi: 10.56936/18291775-2022.33-22